Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-000912

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Feb 15, 2017
Accepted (ET)
Apr 3, 2017 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Feb 15, 2017L10$6.51A82,805IBy: Separately Managed Account
Common StockF1,F5Feb 17, 2017L1$6.51A82,806IBy: Separately Managed Account
Common StockF1,F5Feb 21, 2017L57$6.51A82,863IBy: Separately Managed Account
Common StockF1,F5Mar 3, 2017L22$6.51A82,885IBy: Separately Managed Account
Common StockF1,F5Mar 30, 2017P223$6.51A83,108IBy: Separately Managed Account
Common StockF1holding———20,227D
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF2holding———363,611IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses